Hospital Morales Meseguer-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. Congenital factor XI deficiency and risk of heart failure in humans

    Journal of Thrombosis and Haemostasis

2022

  1. Safety and effectiveness of edoxaban in clinical practice after one year of follow-up in Spain. The ETNA-AF-EUROPE registry

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 39-47

2020

  1. Aortic valve stenosis provides complementary information to bleeding risk scores in non-valvular atrial fibrillation patients initiating anticoagulation

    Journal of Geriatric Cardiology, Vol. 17, Núm. 3, pp. 141-148

  2. Use of edoxaban in clinical practice: Comparison of data from the Spanish population in the ETNA-AF-Europe registry

    Future Cardiology, Vol. 16, Núm. 5, pp. 469-480

2019

  1. Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists

    European Journal of Clinical Investigation, Vol. 49, Núm. 10

2013

  1. Creating a genotype-based dosing algorithm for acenocoumarol steady dose

    Thrombosis and Haemostasis, Vol. 109, Núm. 1, pp. 146-153